Search Result "atherogenic molecules"
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
The Anti-Atherogenic Effects of Thiazolidinediones
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff
Novel Monocyte Biomarkers of Atherogenic Conditions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5859-5864
Author(s): Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov, Julia Kzhyshkowska
Chemokines and Relevant microRNAs in the Atherogenic Process
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18 Issue: 7 Year: 2018 Page: 597-608
Author(s): Dimitry A. Chistiakov,Alexander N. Orekhov,Yuri V. Bobryshev
Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3 Issue: 4 Year: 2003 Page: 243-253
Author(s): Toshimasa Yamauchi, Kazuo Hara, Naoto Kubota, Yasuo Terauchi, Kazuyuki Tobe, Philippe Froguel, Ryozo Nagai, Takashi Kadowaki
Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Journal: Vascular Disease Prevention
Volume: 2 Issue: 2 Year: 2005 Page: 107-114
Author(s): Yehuda Kamari, Irit Avni, Ehud Grossman, Yehonatan Sharabi